Skip to content
Case report Open access

Recurrent thymoma-associated PRCA with persistent agranulocytosis: a case report and therapeutic considerations

Sep 2026 · Frontiers in Oncology · Vol 16 · 0 citations · 35 references
Medicine

TL;DR

Thymoma resection may reduce immune attack on the bone marrow and create conditions favorable for hematopoietic recovery by removing the source of continued generation and export of abnormal T cells; however, abnormal T cells that have already entered the peripheral blood or bone marrow and continue to survive may perpetuate immune-mediated injury.

Abstract

We report a case of recurrent type A thymoma accompanied by pure red cell aplasia (PRCA) and agranulocytosis. Following local recurrence after thymoma resection, the patient gradually developed anemia and leukopenia as the lesion progressed; bone marrow examination showed marked suppression of erythropoiesis and reduced granulopoiesis. Taken together with the peripheral blood findings, these results suggested thymoma-associated immune-mediated hematopoietic injury. Following multidisciplinary evaluation, the patient underwent thoracoscopic resection of the recurrent lesion, and pathological examination confirmed type A thymoma with negative surgical margins. Postoperative follow-up showed gradual recovery of erythropoiesis and achievement of transfusion independence, whereas agranulocytosis persisted; only after regular cyclosporine A treatment and increased drug exposure did the white blood cell and neutrophil counts gradually rise. Based on this case and previous studies, thymoma resection may reduce immune attack on the bone marrow and create conditions favorable for hematopoietic recovery by removing the source of continued generation and export of abnormal T cells; however, abnormal T cells that have already entered the peripheral blood or bone marrow and continue to survive may perpetuate immune-mediated injury. Therefore, blood counts should be monitored serially after surgery, and standardized adjunctive immunosuppressive therapy should be instituted when necessary. During treatment, close attention should also be paid to medication adherence, therapeutic drug concentrations, and monitoring of hepatic and renal function to balance efficacy and safety.

Read PDF

Similar papers

Open access Oct 2026

PO109 | A RARE CASE OF ANEMIA AND THROMBOCYTOPENIA

Background. Fibroblastic reticular cell tumor (FRCT) is an extremly rare neoplasm arising from stromal cells of lymphoid tissues, characterized by aggressive biological behavior and significant diagnostic challenges. Due to its rarity, the current literature is limited to a small number of case reports, underscoring th...

E. Cosi · 0 citations
Open access Oct 2026

Gemcitabine-Induced Thrombotic Microangiopathy: A Case Report

We report the case of a 69-year-old woman with metastatic lung adenocarcinoma who developed severe thrombotic microangiopathy (TMA) only seven days after receiving her first dose of gemcitabine. The patient had pre-existing stage 3a chronic kidney disease and previous exposure to bevacizumab, which may have increased h...

S. Badaoui, M. Bouchoual, S. Anibar et al. · 0 citations
Case report Oct 2026

Early-onset VEXAS syndrome mimicking orbital cellulitis and successfully treated with allogeneic hematopoietic stem cell transplantation

Allogeneic hematopoietic stem cell transplantation may provide effective disease control in refractory cases and VEXAS syndrome should be considered in young adults presenting with unexplained systemic inflammation and cytopenias, even with atypical manifestations such as orbital cellulitis.

Gokhan Burul, C. Karaoglan, E. Bektaş et al. · 1 citation
Case report Open access Oct 2026

Angiomatoid Fibrous Histiocytoma in a Child with Hereditary Spherocytosis: A Rare Co-occurrence

Abstract Introduction: Angiomatoid fibrous histiocytoma (AFH) is a rare soft-tissue tumor of low malignant potential, and its radiological appearance is often non-specific, mimicking benign cysts, hematomas, or infections, necessitating histopathological and immunohistochemical confirmation. While hematological maligna...

Sandeep Sehrawat, V. Kumar, L. Kapoor et al. · 0 citations
Open access Oct 2026

Leukemia cutis mimicking Burkitt lymphoma in a child at Muhimbili National Hospital, Tanzania: a case report

Leukemia cutis (LC) is a rare extramedullary manifestation of leukemia resulting from infiltration of leukemic cells into the skin. Although uncommon in children, LC may represent the initial manifestation of leukemia and can clinically and histopathologically mimic other malignancies, including Burkitt lymphoma, leadi...

H. Munaku, Ruchius Philbert, Lilian Bachuba et al. · 0 citations
Case report Sep 2026

Oral Manifestations and Management of Lymphoma-Associated Hemophagocytic Lymphohistiocytosis.

Hemophagocytic lymphohistiocytosis (HLH) is a severe, life-threatening hyperinflammatory syndrome characterized by dysregulated activation of cytotoxic T-lymphocytes and macrophages, with lymphoma-associated HLH (LA-HLH) carrying a particularly poor prognosis due to delayed diagnosis and lack of optimal treatment regim...

Qi-Yue Luo, Zheng Wang, Jian-Qiu Jin · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.